| Disease Info Index | ||||||||||||||||||||||||||
|
|
|
|
|
Text
|
Exp Diabetes Res Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Ozawa Y, Kurihara T, Sasaki M, Ban N, Yuki K, Kubota S, Tsubota K Laboratory of Retinal Cell Biology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo 160-8582, Japan. Diabetic retinopathy, a vision-threatening disease, has been regarded as a vascular disorder. However, impaired oscillatory potentials (OPs) in the el... Read More Source: PubMed 2011 Dec 6 Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Berner AK, Brouwers O, Pringle R, Klaassen I, Colhoun L, McVicar C, Brockbank S, Curry JW, Miyata T, Brownlee M, Schlingemann RO, Schalkwijk C, Stitt AW Centre for Vision and Vascular Science, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland, UK. AIMS/HYPOTHESIS: Methylglyoxal (MG) is an important precursor for AGEs. Normally, MG is detoxified by the glyoxalase (GLO) enzym... Read More Source: PubMed J Prev Med Public Health Arterial Stiffness is Associated With Diabetic Retinopathy in Korean Type 2 Diabetic Patients. Yun YW, Shin MH, Lee YH, Rhee JA, Choi JS Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Korea. We evaluated the association between common carotid artery intima-media thickness (CCA-IMT), brachial-ankle pulse wave velocity (baPWV), carotid plaqu... Read More Source: PubMed Exp Diabetes Res Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Ozawa Y, Kurihara T, Sasaki M, Ban N, Yuki K, Kubota S, Tsubota K Laboratory of Retinal Cell Biology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo 160-8582, Japan. Diabetic retinopathy, a vision-threatening disease, has been regarded as a vascular disorder. However, impaired oscillatory potentials (OPs) in the el... Read More Source: PubMed 2011 Dec 6 Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Berner AK, Brouwers O, Pringle R, Klaassen I, Colhoun L, McVicar C, Brockbank S, Curry JW, Miyata T, Brownlee M, Schlingemann RO, Schalkwijk C, Stitt AW Centre for Vision and Vascular Science, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland, UK. AIMS/HYPOTHESIS: Methylglyoxal (MG) is an important precursor for AGEs. Normally, MG is detoxified by the glyoxalase (GLO) enzym... Read More Source: PubMed J Prev Med Public Health Arterial Stiffness is Associated With Diabetic Retinopathy in Korean Type 2 Diabetic Patients. Yun YW, Shin MH, Lee YH, Rhee JA, Choi JS Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Korea. We evaluated the association between common carotid artery intima-media thickness (CCA-IMT), brachial-ankle pulse wave velocity (baPWV), carotid plaqu... Read More Source: PubMed Drugs Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-based review. Wilkinson JT, Fraunfelder FW Casey Eye Institute, Oregon Health Science University, Portland, OR, USA. We sought to examine the evidence regarding the use of herbal medicines and nutritional supplements in age-related macular degeneration (AMD), catarac... Read More Source: PubMed 2011 Dec 5 Determination of Diabetic Retinopathy Prevalence and Associated Risk Factors in Chinese Diabetic and Pre-diabetic Subjects: Shanghai Diabetic Complications Study. Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, Gu H, Bao Y, Wu Q, Xiang K, Gao X, Jia W Department of Endocrinology and Metabolism, Shanghai Jiaotong University Affiliated Sixth People's Hospital; Shanghai Clinical Center for Diabetes; Shanghai Key Laboratory of Diabetes Mellitus; Shanghai Diabetes Institute, Shanghai, China. BACKGROUND: The prevalence of diabetic retinopathy is not well-studied in the Chinese pre-diabetic population, also known as impaired glucose regulati... Read More Source: PubMed Drugs Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-based review. Wilkinson JT, Fraunfelder FW Casey Eye Institute, Oregon Health Science University, Portland, OR, USA. We sought to examine the evidence regarding the use of herbal medicines and nutritional supplements in age-related macular degeneration (AMD), catarac... Read More Source: PubMed 2011 Dec 4 Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months. Morphis G, Irigoyen C, Eleuteri A, Stappler T, Pearce I, Heimann H St Paul's Eye Unit, Royal Liverpool University Hospital, Link 8z, Prescot Street, Liverpool, L7 8XP, UK, gmorph@yahoo.com. BACKGROUND: Silicone oil (SO) is an established tamponade in treating complex vitreoretinal diseases. Although SO is intended to... Read More Source: PubMed 2011 Dec 1 Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. van Eijk KN, Blom JW, Gussekloo J, Polak BC, Groeneveld Y Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands. AIM: Although diabetic retinopathy (DR) screening is a basic component of diabetes care, uptake of screening programs is less than optimal. Because at... Read More Source: PubMed 2011 Nov 30 Causes of Blindness and Visual Impairment in Latin America. Furtado JM, Lansingh VC, Carter MJ, Milanese MF, Peńa BN, Ghersi HA, Bote PL, Nano ME, Silva JC Casey Eye Institute, Oregon Health and Science University, Portland Oregon, USA. We review what is known in each country of the Latin American region with regards to blindness and visual impairment and make some comparisons to Hisp... Read More Source: PubMed Ophthalmology Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M, Ferris FL, Glassman AR, Maturi RK, Stockdale CR, Topping TM Joslin Diabetes Center, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. To describe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti-vascular endothelial growth factor (an... Read More Source: PubMed 2011 Dec 5 Determination of Diabetic Retinopathy Prevalence and Associated Risk Factors in Chinese Diabetic and Pre-diabetic Subjects: Shanghai Diabetic Complications Study. Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, Gu H, Bao Y, Wu Q, Xiang K, Gao X, Jia W Department of Endocrinology and Metabolism, Shanghai Jiaotong University Affiliated Sixth People's Hospital; Shanghai Clinical Center for Diabetes; Shanghai Key Laboratory of Diabetes Mellitus; Shanghai Diabetes Institute, Shanghai, China. BACKGROUND: The prevalence of diabetic retinopathy is not well-studied in the Chinese pre-diabetic population, also known as impaired glucose regulati... Read More Source: PubMed 2011 Dec 4 Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months. Morphis G, Irigoyen C, Eleuteri A, Stappler T, Pearce I, Heimann H St Paul's Eye Unit, Royal Liverpool University Hospital, Link 8z, Prescot Street, Liverpool, L7 8XP, UK, gmorph@yahoo.com. BACKGROUND: Silicone oil (SO) is an established tamponade in treating complex vitreoretinal diseases. Although SO is intended to... Read More Source: PubMed 2011 Dec 1 Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. van Eijk KN, Blom JW, Gussekloo J, Polak BC, Groeneveld Y Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands. AIM: Although diabetic retinopathy (DR) screening is a basic component of diabetes care, uptake of screening programs is less than optimal. Because at... Read More Source: PubMed 2011 Nov 30 Causes of Blindness and Visual Impairment in Latin America. Furtado JM, Lansingh VC, Carter MJ, Milanese MF, Peńa BN, Ghersi HA, Bote PL, Nano ME, Silva JC Casey Eye Institute, Oregon Health and Science University, Portland Oregon, USA. We review what is known in each country of the Latin American region with regards to blindness and visual impairment and make some comparisons to Hisp... Read More Source: PubMed Ophthalmology Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M, Ferris FL, Glassman AR, Maturi RK, Stockdale CR, Topping TM Joslin Diabetes Center, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. To describe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti-vascular endothelial growth factor (an... Read More Source: PubMed Ophthalmology Diabetic retinopathy and cardiovascular disease. Tyagi M, Narayanan R Hyderabad, India. ... Read More Source: PubMed Ophthalmology Diabetic retinopathy and cardiovascular disease. Tyagi M, Narayanan R Hyderabad, India. ... Read More Source: PubMed |
| Share it! |
|
|
|
|




|
Posted by:
kelkar(Guest)
Posted on: 01/14/2011 Examination is not prevention. the article dose not answer the question it posed in the heading, How to prevent Diabetic Retinopathy?
Reply |
Forward
|
| Citing this Health Article | ||||||
|
||||||
| News on Diabetic Retinopathy |
|
Women With Gestational Diabetes Have Better Outcomes Via Phone Contact With Nurses |
|
Severity of Sleep Apnea Could Predict Diabetes |
|
Researchers Discover Target for Diabetes Drug |
|
Diabetes Cases Could Rise by 64 Percent in the US by 2025 |
|
Cut-Rate Paper-Based Diabetes Test Apt for Developing Countries |
| Total News Item 1334 | |